1. Home
  2. IVVD vs GOCO Comparison

IVVD vs GOCO Comparison

Compare IVVD & GOCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVVD
  • GOCO
  • Stock Information
  • Founded
  • IVVD 2020
  • GOCO 2001
  • Country
  • IVVD United States
  • GOCO United States
  • Employees
  • IVVD N/A
  • GOCO N/A
  • Industry
  • IVVD Biotechnology: Pharmaceutical Preparations
  • GOCO Specialty Insurers
  • Sector
  • IVVD Health Care
  • GOCO Finance
  • Exchange
  • IVVD Nasdaq
  • GOCO Nasdaq
  • Market Cap
  • IVVD 63.4M
  • GOCO 64.9M
  • IPO Year
  • IVVD 2021
  • GOCO 2020
  • Fundamental
  • Price
  • IVVD $1.34
  • GOCO $4.90
  • Analyst Decision
  • IVVD Strong Buy
  • GOCO Hold
  • Analyst Count
  • IVVD 4
  • GOCO 1
  • Target Price
  • IVVD $3.64
  • GOCO $12.00
  • AVG Volume (30 Days)
  • IVVD 15.0M
  • GOCO 45.4K
  • Earning Date
  • IVVD 11-13-2025
  • GOCO 11-06-2025
  • Dividend Yield
  • IVVD N/A
  • GOCO N/A
  • EPS Growth
  • IVVD N/A
  • GOCO N/A
  • EPS
  • IVVD N/A
  • GOCO N/A
  • Revenue
  • IVVD $46,210,000.00
  • GOCO $822,444,000.00
  • Revenue This Year
  • IVVD $385.94
  • GOCO $2.06
  • Revenue Next Year
  • IVVD $62.62
  • GOCO $5.47
  • P/E Ratio
  • IVVD N/A
  • GOCO N/A
  • Revenue Growth
  • IVVD 1941.08
  • GOCO 17.46
  • 52 Week Low
  • IVVD $0.35
  • GOCO $4.65
  • 52 Week High
  • IVVD $2.74
  • GOCO $21.00
  • Technical
  • Relative Strength Index (RSI)
  • IVVD 66.86
  • GOCO 40.63
  • Support Level
  • IVVD $1.05
  • GOCO $4.65
  • Resistance Level
  • IVVD $1.45
  • GOCO $5.01
  • Average True Range (ATR)
  • IVVD 0.19
  • GOCO 0.24
  • MACD
  • IVVD 0.05
  • GOCO 0.01
  • Stochastic Oscillator
  • IVVD 83.82
  • GOCO 27.72

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

About GOCO GoHealth Inc.

GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions so consumers can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. Its proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.

Share on Social Networks: